Mairene Coto‐Llerena
- Hepatology top 5%
- Hepatitis C virus research 15
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 4
- Oncology top 10%
- Cancer Cells and Metastasis 4
-
- RNA modifications and cancer 4
-
- Hepatitis B Virus Studies 11
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Salvatore PiscuoglioCaner ErcanMarkus H. HeimRavi Kiran Reddy KalathurGerhard ChristoforiDavid BuechelFengyuan TangRuize Gao
- Partner nations
- SwitzerlandSpainItaly
In The Last Decade
Mairene Coto‐Llerena
38 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Hepatology 279
- Cancer Research 436
- Pulmonary and Respiratory Medicine 351
- Oncology 243
- Molecular Biology 608
Countries citing papers authored by Mairene Coto‐Llerena
This map shows the geographic impact of Mairene Coto‐Llerena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mairene Coto‐Llerena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mairene Coto‐Llerena more than expected).
Fields of papers citing papers by Mairene Coto‐Llerena
This network shows the impact of papers produced by Mairene Coto‐Llerena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mairene Coto‐Llerena. The network helps show where Mairene Coto‐Llerena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mairene Coto‐Llerena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | Arginine reprograms metabolism in liver cancer via RBM39breakdown → | 2023 | 145 |
| 3 | 2023 | 15 | |
| 4 | 2022 | 88 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 17 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 10 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 50 | |
| 14 | 2020 | 6 | |
| 15 | 2018 | 75 | |
| 16 | 2014 | 21 | |
| 17 | 2014 | 5 | |
| 18 | 2013 | 4 | |
| 19 | 2011 | 63 | |
| 20 | 2011 | 13 |
About Mairene Coto‐Llerena
Mairene Coto‐Llerena is a scholar working on Hepatology, Cancer Research and Virology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (4 papers), RNA modifications and cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (279 citations), Cancer Research (436 citations) and Pulmonary and Respiratory Medicine (351 citations). Mairene Coto‐Llerena has collaborated with scholars based in Switzerland, Spain and Italy. Frequent co-authors include Salvatore Piscuoglio, Caner Ercan, Markus H. Heim, Ravi Kiran Reddy Kalathur, Gerhard Christofori, David Buechel, Fengyuan Tang, Ruize Gao, Michael T. Dill and Shuang Song. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.